Enlighta Inc.

Enlighta Inc.

NLTA.V
Enlighta Inc.CA flagToronto Stock Exchange Ventures
0.07
CAD
- -
- -
1.11MMarket Cap
Enlighta Inc.
NLTA.V
(Toronto Stock Exchange Ventures)

Recent

price

0.07

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Enlighta Inc. (TSXV:NLTA) operates as a development-stage healthcare technology company focused on digital health solutions, including virtual medical care, disease management platforms, and clean technology offerings in the medical sector; its core products encompass software for third-party risk management (TPRM), vendor governance, supplier performance monitoring, contract compliance, risk assessment, and relationship management, leveraging AI, automation, machine learning, and integrations with enterprise systems such as CLM, ERP, GRC, and VMS tools. The company, founded in 2002 and headquartered in San Ramon, California, as a California corporation, maintains global development and services centers, targeting enterprises in healthcare, pharmaceuticals, and other industries requiring robust vendor lifecycle management across regions including North America, Europe, and Asia. Recent developments include a 2024 partnership with PepsiCo that won the Future of Sourcing Award for Innovations in Governance/Compliance from SIG, a transfer to the NEX board in 2025 due to TSX Venture Exchange listing requirements, celebration of its 20-year anniversary with new clients and record revenues noted in early 2022, and ongoing expansions in pharma-healthcare compliance solutions.